The global High Content Screening Market is experiencing significant growth as pharmaceutical companies, biotechnology organizations, and research institutions increasingly focus on advanced drug discovery and cellular analysis technologies. The market was valued at US$ 764.40 million in 2025 and is projected to reach US$ 1,642.20 million by 2034, registering a compound annual growth rate of...